Inventor
HITTINGER AUGUSTIN
FR17 patents
⚠️ This page may combine multiple inventors who share the name “HITTINGER AUGUSTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA SA
15 patentsUS6479479B2Nov 12, 2002
Azetidine derivatives, their preparation and pharmaceutical compositions containing them
AVENTIS PHARMA SA81 citations97
US6355631B1Mar 12, 2002
Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
AVENTIS PHARMA SA107 citations97
US6734176B2May 11, 2004
Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
AVENTIS PHARMA SA47 citations96
US6566356B2May 20, 2003
Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
AVENTIS PHARMA SA60 citations96
US6518264B2Feb 11, 2003
Azetidine derivatives, their preparation and medicaments containing them
AVENTIS PHARMA SA68 citations95
US6872717B2Mar 29, 2005
Pharmacological uses of azetidine derivatives
AVENTIS PHARMA SA35 citations92
US6858603B2Feb 22, 2005
Acetindine derivatives, their preparation and medicaments containing them
AVENTIS PHARMA SA28 citations92
US7354933B2Apr 8, 2008
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA27 citations90
US7528147B2May 5, 2009
Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
AVENTIS PHARMA SA8 citations82
US6995175B2Feb 7, 2006
Chemical derivatives and their application as antitelomerase agent
AVENTIS PHARMA SA7 citations74
US7132414B2Nov 7, 2006
Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
AVENTIS PHARMA SA9 citations73
US7741316B2Jun 22, 2010
Pharmacological uses of azetidine derivatives
AVENTIS PHARMA SA0 citations52
US7968566B2Jun 28, 2011
Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
AVENTIS PHARMA SA0 citations51
US7825115B2Nov 2, 2010
Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA1 citations50
US7759379B2Jul 20, 2010
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA1 citations50